CYSLTR1 and neoplasm: We have shown that the up-regulated CysLT1R tumor expression in breast and colorectal cancer patients predicts a negative prognosis [11, 16], whereas concurrent low CysLT1R and high CysLT2R expression in colonic tumors convey a favorable prognosis [17].